COMMUNIQUÉS West-GlobeNewswire

Carbios annonce une évolution de sa gouvernance et la nomination de Benoît Grenot en qualité de Directeur Général.
18/05/2026
Clermont-Ferrand (France), 18 mai 2026 (17h45 CEST). Carbios (Euronext Growth Paris : ALCRB) annonce une évolution de sa gouvernance. Ayant à 64 ans fait part de sa volonté de partir à la retraite, Vincent Kamel [...]
Capitol Hill Briefing To Spotlight Critical Health Care Services for Adults With Communication Disorders
18/05/2026
ASHA Collaborates With Co-Chairs of the Unified Voices Caucus, Reps. Kat Cammack and Troy Carter, for May 20 Event Rockville, Md., May 18, 2026 (GLOBE NEWSWIRE) -- In recognition of National Speech-Language-Hearing [...]
Upstream Bio Presents New Data from Phase 2 VIBRANT Trial of Verekitug Demonstrating Improvement in Asthma Symptom Control in Participants with CRSwNP and Comorbid Asthma at the ATS 2026 International Conference
18/05/2026
– Verekitug led to statistically significant and clinically meaningful improvement in asthma symptom control as measured by the Asthma Control Questionnaire-6 (ACQ-6) in participants with CRSwNP and comorbid asthma – – [...]
Philips highlights advances in imaging and physiology to support complex PCI at EuroPCR 2026
18/05/2026
May 18, 2026 From imaging to AI-enabled guidance, Philips connects technologies into a unified workflow to improve efficiency, reduce radiation exposure and support procedural confidence Amsterdam, the Netherlands – As [...]
Arvinas Employees Give Back During Company-wide Impact Day
18/05/2026
NEW HAVEN, Conn., May 18, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to create a new class of drugs based on targeted protein degradation, today announced that [...]
UPDATE - Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD
18/05/2026
Data from Phase 2a study of LAM-001 on top of standard of care in PH-ILD patients with refractory PH demonstrated clinically meaningful improvement in multiple assessments of lung function, including improvement in 6MWD [...]
Arbor Biotechnologies Appoints Mathew Pletcher, Ph.D., as Chief Scientific Officer
18/05/2026
Gene therapy and rare disease leader with nearly two decades of drug development experience to focus on advancing the company’s next-generation gene editing pipeline CAMBRIDGE, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- [...]
Red Ribbon Recovery Indiana reports strong patient outcomes in first year of operation
18/05/2026
New Indiana rehab reports 88% sobriety at 30 days — and 70% at six months Greenwood, Indiana, May 18, 2026 (GLOBE NEWSWIRE) -- Red Ribbon Recovery Indiana, which marks its first year of operation this June, is releasing [...]
Philips introduces SmartIQ to address the trade-off between image quality and radiation dose in coronary procedures
18/05/2026
May 18, 2026 Greater differentiation of clinical details through contrast-rich images with reduced background noise For coronary procedures, a new ultra-low dose protocol employs over 50% less X-ray radiation dose [1] [...]
Novo Nordisk A/S - share repurchase programme
18/05/2026
Bagsværd, Denmark,18 May 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and [...]
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership for the Transformative Bio-Hermes-002 Study
18/05/2026
Bio-Hermes-002 is a collaborative study focused on new biomarkers designed to improve diagnosis of Alzheimer's disease and dementias WASHINGTON, D.C., May 18, 2026 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform [...]
Quince Announces Acquisition of Orphai and up to $187 Million Private Placement to Advance Pulmonary Pipeline
18/05/2026
Acquisition includes LAM-001, an inhaled formulation of rapamycin for multiple pulmonary diseases, including pulmonary hypertension associated with interstitial lung disease (PH-ILD) and bronchiolitis obliterans [...]
Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD
18/05/2026
Data from Phase 2a study of LAM-001 on top of standard of care in PH-ILD patients with refractory PH demonstrated clinically meaningful improvement in multiple assessments of lung function, including improvement in 6MWD [...]
GRI Bio to Present at A.G.P.’s Annual Healthcare Company Showcase
18/05/2026
Live webcast fireside chat with Marc Hertz, PhD, Chief Executive Officer, on Wednesday, May 20, 2026 Register for the event here LA JOLLA, CA, May 18, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or [...]
Akari Therapeutics to Present at A.G.P.’s Annual Healthcare Company Showcase
18/05/2026
Live webcast fireside chat with Abizer Gaslightwala, President and Chief Executive Officer, on Wednesday, May 20, 2026 Register for the event here TAMPA, Fla. and LONDON, May 18, 2026 (GLOBE NEWSWIRE) -- Akari [...]
Aradigm Brings Cell and Gene Therapy Benefits Platform to Quantum Health’s Customers
18/05/2026
Collaboration will help employers manage catastrophic financial risk while ensuring access to life-changing treatments NEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- Aradigm , the market’s first comprehensive, transparent [...]
Parexel Launches ParexelAI™, Delivering AI Innovation to Accelerate Clinical Development
18/05/2026
Innovative, proprietary suite of artificial intelligence services and capabilities deliver proven speed, quality and efficiency results for sponsors and patients RALEIGH, N.C., May 18, 2026 (GLOBE NEWSWIRE) -- Parexel, [...]
Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live]
18/05/2026
GAITHERSBURG, Md., May 18, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS), a global biodefense company, today announced that the Saudi Food and Drug Authority (SFDA) has approved the registration of ACAM2000 [...]
Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation
18/05/2026
THE WOODLANDS, TX, May 18, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today [...]

Pages